Ondine Biomedical Inc. (AIM:OBI)

Ondine Biomedical Revenue

Ondine Biomedical had revenue of 1.01M CAD in the half year ending June 30, 2025, with 136.68% growth. This brings the company's revenue in the last twelve months to 2.20M, up 34.82% year-over-year. In the year 2024, Ondine Biomedical had annual revenue of 2.05M with 70.32% growth.

• Revenue (ttm): 2.20M CAD
• Revenue Growth: +34.82%
• P/S Ratio: 49.93
• Revenue / Employee: 122.39K CAD
• Employees: 18
• Market Cap: 58.86M GBP

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.05M	846.00K	70.32%
Dec 31, 2023	1.20M	565.00K	88.56%
Dec 31, 2022	638.00K	-1.93M	-75.17%
Dec 31, 2021	2.57M	778.00K	43.44%
Dec 31, 2020	1.79M	258.16K	16.84%